We are developing a cutting-edge device platform to scale global manufacturing capacity, enabling cost-effective and safe cell therapies for all patients.


Facts about cell therapy

85%

complete remission in r/r ALL patients
after a cell therapy treatment

Source

44%

still cancer free, four years after a single infusion of a cell therapy

Source

<1%

of all blood cancer patients receive
a cell therapy

320K

price in EUR of a cell therapy
Kymriah, Germany 2020


Vision

Motivation

Cell Therapy transformed cancer treatment. Sarcura will transform cell therapy manufacturing.

Daniela Buchmayr, MBA
CEO


Sarcura's Solution

Technology

Automation

Industrial automation increases product quality and scalability

Integration

Integrated process and quality control facilitates real-time process information

Miniaturization

Silicon and microfluidic structures enable processing on cellular level

Modularity

Functional modules allow individual process designs and conceptional flexibility


Related News

Journal

Supported by

Partners